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ELECTRONIC LETTER
Isolated Robin sequence associated with a balanced t(2;17)
chromosomal translocation
N Jamshidi, I Macciocca, P A Dargaville, P Thomas, N Kilpatrick, R J McKinlay Gardner, P G Farlie
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
J Med Genet 2004;41:e1 (http://www.jmedgenet.com/cgi/content/full/41/1/e1)
R
obin sequence (RS) is a developmental malformation
characterised by micrognathia, cleft palate, and gloss-
optosis, leading to respiratory and feeding difficulties in
the majority of affected neonates.1 2 These three features
constitute the primary diagnostic criteria of RS, although
diagnosis on the basis of any two of these three classical
features has been suggested.3 Typically the condition occurs
sporadically, but it may be familial, in which case the mode of
inheritance is autosomal dominant.4 5 However, the patho-
genetic and phenotypic variability of RS has hampered efforts
to establish a clear set of diagnostic criteria,3 6 7 making the
classification of this anomaly difficult and complicating the
effective management and treatment.8 9 Hence, the diagnosis
of RS presents a challenge from both a clinical and a
developmental perspective.
RS has three different manifestations: (a) as part of a
known syndrome; (b) in association with other abnormalities
that do not constitute a recognisable syndrome (non-
syndromic), and (c) in a classical or isolated form not
associated with any other significant findings.3 6 10
Approximately 20–40% of reported RS cases occur in an
isolated form, while between 35 and 70% of cases are
syndromic.11–15 The most common syndromes associated with
RS include Stickler syndrome and velocardiofacial syn-
drome.15 16 While the underlying genetic factors in a number
of the syndromes that include RS have been delineated,17–19
the genetic basis for isolated RS remains unclear.
The developmental basis of RS is still contentious and it is
conceivable that more than one pathogenic mechanism may
be responsible for the full range of RS manifestations. One
proposed theory for the origin of RS argues that mandibular
hypoplasia, resulting from a developmental anomaly in either
growth or placement of the mandible, is the primary defect.20
The cleft palate and apnoea could thus be a consequence of
reduced oropharyngeal volume. This is supported by the
elimination of both cleft palate and/or glossoptosis in the
definition for PRS by some authors.10 21–23 Further support for
this hypothesis comes from an experimental paradigm of RS
in which mandibular hypoplasia and relative macroglossia
precede palatal closure.24 An alternative developmental
sequence for RS centres on the hindbrain region regulating
oro-oesophageal motor function.25–28 According to this theory,
oral motility required for mandibular growth is disrupted in
the early fetal period, and mandibular hypoplasia is a
secondary consequence of these neuronal or neuromuscular
deficits.29 This model is supported by experimental findings of
cleft palate and mandibular hypoplasia in an induced model
of oropharyngeal muscular degeneration.30
While non-genetic aetiologies for RS have been pro-
posed,31 32 there are a number of reported cases describing
chromosomal abnormalities associated with the non-syndro-
mic or isolated RS33–37 implicating an underlying genetic
component (table 1). Vintiner et al reported a balanced
translocation t(5;17)(q15;q23) in all affected individuals of a
single family during screening for Stickler syndrome.33
However, together with RS, the clinical phenotype of the
family included arthropathy of varying severity among the
affected individuals, a feature not typical of classical RS.
Additional reports have also indicated that there may be an
RS locus at 17q23.3–2534 36 although no gene has been
isolated. Moreover, Houdayer et al reported a case of non-
syndromic RS that co-segregated with an unbalanced
reciprocal translocation involving an interstitial deletion of
chromosome 2 (2q32.3–q33.2), and suggested this locus as a
candidate region for non-syndromic RS.35 This hypothesis is
further strengthened by a previous report indicating involve-
ment of the 2q32 locus in the pathogenesis of isolated cleft
palate.38
In addition to reports of cytogenetic abnormalities, a recent
study provides support for the existence of multiple genetic
loci for RS with the identification of sequence variations in
the COL2A1, COL11A1, and COL11A2 genes in a number of
unrelated patients with non-syndromic RS.39 The role for
these variations in the aetiology of RS has yet to be clarified,
but their discovery along with evidence of distinct cytogenetic
anomalies highlights the aetiological heterogeneity asso-
ciated with RS. Thus, several promising loci associated with
isolated RS await further characterisation.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Abbreviations: BAC, bacterial artificial chromosome; FISH, fluorescent
in situ hybridisation; RS, Robin sequence
Key points
N Robin sequence (RS) is a developmental anomaly
characterised by micrognathia, cleft palate, and
glossoptosis. To date, no known genes have been
demonstrated to cause isolated RS.
N We report a family with isolated RS in which this
condition co-segregates with a balanced reciprocal
t(2;17)(q24.1;24.3) translocation over three genera-
tions.
N The breakpoints were localised using fluorescence in
situ hybridisation walking to a region between probes
RP11-157M22 and RP11-611G1 on chromosome 2,
and RP11-147L13 and RP11-261A13 on chromosome
17.
N We propose that this reciprocal translocation has
disrupted a putative gene or a regulatory element at
one or both translocation breakpoints.
N This family represents a unique resource for the
molecular genetic study of craniofacial development
and has the potential to enable the identification of the
developmental progression leading to RS.
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We identified a family in which a balanced reciprocal
translocation (2;17)(q24.1;24.3) co-segregates with the class-
ical isolated form of RS across three generations.
Characterisation of the cytogenetic anomaly in this family
has narrowed the breakpoint to a defined region delineated
by two bacterial artificial chromosome (BAC) probes on each
chromosome. We anticipate that the identification of a
disrupted gene(s) due to the translocation in this family will
enable further genetic studies that may elucidate the under-
lying aetiology of RS, leading to a better understanding of
this aspect of craniofacial development.
MATERIALS AND METHODS
Family study
The family came to our notice when the proband (III:1) was
born at term with the classical features of RS. The parents
were not consanguineous. Family history revealed that the
father (II:1) and other members of his family had had RS as
children (figs 1 and 2). Clinical assessment was undertaken
by personal examination, perusal of childhood photographs
provided by the family, and review of medical records. These
were performed with the informed consent of the adult
family members, and the study was approved by the RCH
Ethics in Human Research Committee. The clinical presenta-
tion in all affected individuals is summarised in table 2.
Pregnancy histories were unremarkable. At birth, the pro-
band presented with micrognathia, cleft palate, and moder-
ate airway obstruction requiring prone positioning. A
nasopharyngeal tube was required for airway support for
7 days and nasogastric feeding was continued until 9 months
of age. Birth weights and neonatal indices were otherwise
essentially normal. The external ears were normal in shape
and placement and no other malformations were identified
beyond that due to the micrognathia. No other skeletal
abnormalities were noted in the family and a skeletal survey
of the proband was unremarkable, indicating normal ribs and
scapula. Developmental progress and school achievement has
been apparently normal. Ophthalmological examination in
members I:2, II:1, II:8, II:9 with specific reference to the
possibility of Stickler syndrome gave uniformly normal
findings.
Cytogenetic and fluorescent in situ hybridisation
studies
Peripheral blood samples for chromosome analysis were
processed according to standard techniques, and preparations
were analyzed using G-banding. Dual colour fluorescent in
situ hybridisation (FISH) was performed on metaphase
chromosome spreads of the patients with the (2;17)
translocation using BAC clones according to the method of
Pinkel et al with some modifications.40 The BAC clones were
obtained from BACPAC Resources at the Murdoch Institute,
Melbourne, Australia. Images were captured using a Zeiss
Axioscope fluorescence microscope equipped with a cooled
CCD camera (Photometrics, Huntingdon Beach, CA, USA)
Table 1 Clinical findings in reported cases with chromosomal rearrangement involving
chromosome 2 and/or 17
Classical RS
phenotype Other findings Cytogenetics FISH data References
+ None t(2; 17)(q23; q23.3) t(2; 17)(q24.1; q24.3) Present case
+ Limb, ear
abnormalities
t(2; 21)(q33.2;q21.2) t(2; 21)(q32.3–q33.2) Houdayer et al35
+ Other skeletal
abnormalities
t(13;17)(q22.1;q23.3) Not described Stalker et al36
+ None t(3;17)(q25Rqter) Not described Luke et al34
+ Ear abnormalities t(5;17)(q15;q23) Not described Vintiner et al33
Figure 1 Pedigree of the family. The
propositus is III:1. Closed symbols
indicate RS and translocation
heterozygosity; open symbols indicate
unaffected and normal karyotype.
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and analyzed by IPlab Software (Scanalytics, Fairfax, VA,
USA).
RESULTS
Conventional cytogenetic examination on the G-banded
metaphase chromosomes of the proband showed an appar-
ently balanced translocation involving the long arms of
chromosomes 2 and 17, 46XX,t(2;17)(q23;q23.3). The father
carried the same translocation, while the maternal karyotype
was normal. Subsequent investigation revealed the translo-
cation in all the other family members with isolated RS (I:2,
II:1, II:8, II:9, III:6), but in none of the unaffected family
members who was tested. This translocation appeared
identical in each case.
Further detailed mapping of the breakpoints was per-
formed by FISH using BAC clones from the RP11 library that
have been mapped to the chromosomal regions 2q21.3–q25.1
and 17q21.2–q25.3. BAC clones were selected by searching
the NCBI Human Genome Database (www.ncbi.nlm.nih.-
gov). The BAC clone RP11-157M22 produced a signal on both
normal chromosome 2 and the derivative chromosome 2
(der(2)), while RP11-611G1 hybridised to both the normal 2
and der(17) chromosomes (fig. 3A,B). The BAC clone RP11-
147L13 revealed hybridisation signals on the normal17 and
der(17) chromosomes, while RP11-261A13 shows a signal on
both normal 17 and der(2) chromosomes (fig 3C,D). The
FISH analysis did not indicate any deletion, and confirmed
the nature of the reciprocal translocation.
DISCUSSION
We have identified a balanced (2;17) translocation segregat-
ing in the reported family for three generations. The balanced
reciprocal chromosome translocation involving chromosomes
2 and 17 was present in all six family members with isolated
RS, and in none of the unaffected members who were tested.
This complete co-segregation of karyotype with respect to
phenotype in the six individuals strongly points to a causal
connection, and we thus draw the conclusion that an RS
locus exists at one or other of the translocation breakpoints.
The FISH analysis indicated that the breakpoint on chromo-
some 2 mapped to the interval between BAC clones RP11-
157M22 and RP11-611G1 on the band q24.1, while the
breakpoint on chromosome 17 was located between RP11-
147L13 and RP11-261A13 on band q24.3. This is the first
detailed description of a balanced chromosomal translocation
involving chromosomes 2 and 17 in a family with isolated RS.
Previous reports indicate that a distinct, clinically recogni-
sable syndrome involving deletions of chromosome 2q23–
24.3 region may exist.41 Furthermore, there are a number of
cases reported with similar craniofacial abnormalities asso-
ciated with microdeletions on chromosome 17 (q21–q24).42
Micrognathia and palatal defects commonly feature in
patients harbouring deletions on both chromosomes,
although the phenotypes described are much broader than
that in the family described here. These findings further
support the contention that one or more genes involved in
craniofacial development are harboured at these loci,
although micrognathia may also be viewed as a common,
non-specific feature of such deletions.43
There is only a single reported case of non-syndromic RS
implicating 2q3235 but no evidence of a locus at 2q23–24. In
contrast, four examples of RS including the current study
have been described with translocations involving the
17q23.3–17q25 region33 34 36 (table 1). So far, there have been
no available data defining the exact breakpoint region on
chromosome 17. Thus, while the involvement of a locus on
chromosome 2q24 cannot be excluded, the case does seem
stronger in favour of the location of the gene responsible for
isolated RS to be at chromosome 17q24.1.
Figure 2 Lateral and frontal view of
proband illustrating pronounced
micrognathia.
Table 2 Summary of clinical features of the affected
members of the present family with the chromosomal
translocation
Clinical appearance I:2 II:1 II:8 II:9 III:1* III:6




Soft + + + +
Glossoptosis ND + 2 + 2 2
Airway obstruction 2 2 2 + 2 2
Marked neonatal feeding
and swallowing problems
2 2 2 + 2 2
Nasopharyngeal ND + + + 2 +
incompetence
*Proband.
Classification according to the definitions provided by Abadie et al.29
Complete CP: all secondary palate absent; incomplete CP: part of the
secondary palate absent; soft CP: whole bony palate present.
ND, not described.
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As the first step towards positional cloning of the putative
gene affected by this t(2;17) translocation, we have defined
the 2q24.1 translocation breakpoints within a region less
than 1 Mb in length flanked by BACs RP11-157M22 and
RP11-611G1, and the 17q24.3 breakpoint within a 2 Mb
region between BACs RP11-147L13 and RP11-261A13 (fig 3).
These results provide a scaffold for the cloning of the
translocation breakpoints and identification of a disrupted
gene.
Mutations in the SOX9 gene cause skeletal abnormalities
that often include cleft palate.44 The location of the break-
point in this family close to the SOX9 region at 17q24–25
raised the possibility that disruption of the SOX9 gene or its
regulatory elements was responsible for the occurrence of RS.
FISH analysis using BACs centromeric to SOX9 revealed a
signal on the normal chromosome 17 as well as the derivative
chromosome 2, thereby demonstrating that the SOX9 region
was not affected by the breakpoint. In addition, the findings
of Melkoniemi et al39 regarding collagen gene mutations in RS
patients are not relevant in this case, as none of these genes
reside on chromosome 2 or 17.
This left a number of potential candidate genes located in
the breakpoint regions (fig 3). It is interesting that the
known genes in the region are highly expressed in neuronal
and skeletal muscle tissues, in particular MAP2K6, KCNJ16,
and KCNJ2 on chromosome 17 and KCNJ3, located on
chromosome 2. Further molecular characterisation of these
breakpoints is currently underway in our laboratory to
identify the putative gene for isolated RS in this family. We
anticipate that its discovery will contribute substantially to
the understanding of the pathogenesis of RS, and to a wider
knowledge of oro- and cranio-facial development.
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